Jade Biosciences (JBIO) Other Non-Current Assets (2021 - 2026)
Jade Biosciences (JBIO) posted Other Non-Current Assets of $69000.0 for Q1 2026, little changed on a QoQ basis from $69000.0 in Q4 2025.
Jade Biosciences (JBIO) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Jade Biosciences' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $69000.0 for Q1 2026.
- Quarterly Other Non-Current Assets changed N/A year-over-year to $69000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69000.0 (changed N/A YoY) and the FY2025 annual result came in at $69000.0, down 97.81% from the prior year.
- Other Non-Current Assets was $69000.0 for Q1 2026 at Jade Biosciences, roughly flat from $69000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $3.1 million in Q4 2024 and bottomed at $60000.0 in Q2 2025.
- A 5-year average of $1.3 million and a median of $903500.0 in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 747.68% — and 2025, when it sank 97.81%.
- Jade Biosciences' Other Non-Current Assets stood at $2.6 million in 2022, then dropped by 10.78% to $2.3 million in 2023, then soared by 37.7% to $3.1 million in 2024, then sank by 97.81% to $69000.0 in 2025, then changed by 0.0% to $69000.0 in 2026.
- Business Quant data shows JBIO's Other Non-Current Assets at $69000.0 in Q1 2026, $69000.0 in Q4 2025, and $174000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | 69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 69,000.00 |
| Sep 30, 2025 | 174,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Dec 31, 2024 | 3.15 Mn |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | 81,000.00 |
| Mar 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 2.24 Mn |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | 2.65 Mn |
| Dec 31, 2022 | 2.56 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 731,000.00 |
| Mar 31, 2022 | 327,000.00 |
| Dec 31, 2021 | 302,000.00 |
| Sep 30, 2021 | 278,000.00 |
| Jun 30, 2021 | 3.09 Mn |